Implications of socio-cultural contexts for the ethics of clinical trials.

BACKGROUND: Health technology assesment (HTA) requires scientifically rigorous experimentation involving patients as subjects. HTA itself is required so that treatment given to patients will be both effective and efficient; this requirement is itself ethical in nature. At the same time it is essenti...

Full description

Bibliographic Details
Main Authors: Ashcroft, Chadwick, Clark, Edwards, Frith, Hutton
Format: Article
Language:English
Published: NIHR Journals Library 1997-01-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta1090
id doaj-7da6b6d23174470685358594f450e9e6
record_format Article
spelling doaj-7da6b6d23174470685358594f450e9e62020-11-24T23:33:10ZengNIHR Journals LibraryHealth Technology Assessment1366-52781997-01-011910.3310/hta1090Implications of socio-cultural contexts for the ethics of clinical trials.AshcroftChadwickClarkEdwardsFrithHuttonBACKGROUND: Health technology assesment (HTA) requires scientifically rigorous experimentation involving patients as subjects. HTA itself is required so that treatment given to patients will be both effective and efficient; this requirement is itself ethical in nature. At the same time it is essential that the methods used in HTA are ethically sound. Most healthcare researchers agree that the most effective and soundest method for assessing treatments is the randomised controlled trial (RCT). However, some researchers believe that the RCT is unethical, either in essence, or for use in some forms of medical research and HTA. Furthermore, many patients seem unable to understand the principles and purposes of the RCT, a factor which is highly detrimental for the validity of informed consent. Informed consent is the key to the ethics of medical research, both in most theories and in all codes of research conduct. Many RCTs therefore risk being unethical in practice, even if ethical in principle. AIM OF REPORT: To survey the main objections to the RCT and its alternatives. To assess the philosophical and methodological basis of these objections, and of the methods recommended for addressing them. To identify areas where objections are founded in social or cultural factors normally overlooked in ethical argument about the RCT methodology. To identify alternative arguments or methods which might resolve ethical conflicts in this area. HOW THE RESEARCH WAS CONDUCTED: The methods used were adapted from systematic reviews in medicine. Systematic searches of Medline, Psychlit and Sociofile CD-ROM databases; hand-searches of the major journals in general medicine and surgery, medical ethics and philosophy; and searches of books were carried out. The literature survey was restricted to articles published or abstracted in English. A database of the most relevant and useful materials was compiled, and is accessible on the Internet (http://www.liv.ac.uk/sdthomps/page1.html). RESEARCH FINDINGS: UNDERSTANDING RCTS AND THEIR ALTERNATIVES: There is some evidence of difficulty in understanding the aims and methods of RCTs, and some disquiet about elements of the RCT methodologies. These objections are well known and much discussed, and concern the use of placebo, the continuation of trials after significant differentials in benefit or harm are apparent, and randomisation. CULTURAL OR RELIGIOUS OBJECTIONS: There was an absence of evidence of cultural or religious objections to randomisation, placebo or other kinds of controlled prospective trials. This most likely reflects an absence of research rather than absence of objections. (ABSTRACT TRUNCATED)https://doi.org/10.3310/hta1090
collection DOAJ
language English
format Article
sources DOAJ
author Ashcroft
Chadwick
Clark
Edwards
Frith
Hutton
spellingShingle Ashcroft
Chadwick
Clark
Edwards
Frith
Hutton
Implications of socio-cultural contexts for the ethics of clinical trials.
Health Technology Assessment
author_facet Ashcroft
Chadwick
Clark
Edwards
Frith
Hutton
author_sort Ashcroft
title Implications of socio-cultural contexts for the ethics of clinical trials.
title_short Implications of socio-cultural contexts for the ethics of clinical trials.
title_full Implications of socio-cultural contexts for the ethics of clinical trials.
title_fullStr Implications of socio-cultural contexts for the ethics of clinical trials.
title_full_unstemmed Implications of socio-cultural contexts for the ethics of clinical trials.
title_sort implications of socio-cultural contexts for the ethics of clinical trials.
publisher NIHR Journals Library
series Health Technology Assessment
issn 1366-5278
publishDate 1997-01-01
description BACKGROUND: Health technology assesment (HTA) requires scientifically rigorous experimentation involving patients as subjects. HTA itself is required so that treatment given to patients will be both effective and efficient; this requirement is itself ethical in nature. At the same time it is essential that the methods used in HTA are ethically sound. Most healthcare researchers agree that the most effective and soundest method for assessing treatments is the randomised controlled trial (RCT). However, some researchers believe that the RCT is unethical, either in essence, or for use in some forms of medical research and HTA. Furthermore, many patients seem unable to understand the principles and purposes of the RCT, a factor which is highly detrimental for the validity of informed consent. Informed consent is the key to the ethics of medical research, both in most theories and in all codes of research conduct. Many RCTs therefore risk being unethical in practice, even if ethical in principle. AIM OF REPORT: To survey the main objections to the RCT and its alternatives. To assess the philosophical and methodological basis of these objections, and of the methods recommended for addressing them. To identify areas where objections are founded in social or cultural factors normally overlooked in ethical argument about the RCT methodology. To identify alternative arguments or methods which might resolve ethical conflicts in this area. HOW THE RESEARCH WAS CONDUCTED: The methods used were adapted from systematic reviews in medicine. Systematic searches of Medline, Psychlit and Sociofile CD-ROM databases; hand-searches of the major journals in general medicine and surgery, medical ethics and philosophy; and searches of books were carried out. The literature survey was restricted to articles published or abstracted in English. A database of the most relevant and useful materials was compiled, and is accessible on the Internet (http://www.liv.ac.uk/sdthomps/page1.html). RESEARCH FINDINGS: UNDERSTANDING RCTS AND THEIR ALTERNATIVES: There is some evidence of difficulty in understanding the aims and methods of RCTs, and some disquiet about elements of the RCT methodologies. These objections are well known and much discussed, and concern the use of placebo, the continuation of trials after significant differentials in benefit or harm are apparent, and randomisation. CULTURAL OR RELIGIOUS OBJECTIONS: There was an absence of evidence of cultural or religious objections to randomisation, placebo or other kinds of controlled prospective trials. This most likely reflects an absence of research rather than absence of objections. (ABSTRACT TRUNCATED)
url https://doi.org/10.3310/hta1090
work_keys_str_mv AT ashcroft implicationsofsocioculturalcontextsfortheethicsofclinicaltrials
AT chadwick implicationsofsocioculturalcontextsfortheethicsofclinicaltrials
AT clark implicationsofsocioculturalcontextsfortheethicsofclinicaltrials
AT edwards implicationsofsocioculturalcontextsfortheethicsofclinicaltrials
AT frith implicationsofsocioculturalcontextsfortheethicsofclinicaltrials
AT hutton implicationsofsocioculturalcontextsfortheethicsofclinicaltrials
_version_ 1725531898722123776